ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 50 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $2,551,000 | -9.8% | 2,415,000 | -9.4% | 0.01% | 0.0% |
Q2 2017 | $2,827,000 | +10.1% | 2,665,000 | 0.0% | 0.01% | +12.5% |
Q1 2017 | $2,567,000 | +41.3% | 2,665,000 | +36.5% | 0.01% | +33.3% |
Q3 2016 | $1,817,000 | +21.6% | 1,953,000 | -7.6% | 0.01% | 0.0% |
Q2 2016 | $1,494,000 | – | 2,113,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 83,741,000 | $95,429,000 | 6.49% |
STEELHEAD PARTNERS LLC | 52,496,000 | $59,911,000 | 5.47% |
SILVERBACK ASSET MANAGEMENT LLC | 23,000,000 | $26,278,000 | 4.02% |
Castle Creek Arbitrage, LLC | 10,734,000 | $12,253,000 | 3.09% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 40,132,000 | $45,920,000 | 2.81% |
Sonora Investment Management, LLC | 16,707,000 | $19,084,000 | 1.99% |
TFG Asset Management GP Ltd | 8,500,000 | $9,718,000 | 1.73% |
Verition Fund Management LLC | 27,901,000 | $31,890,000 | 0.88% |
SSI INVESTMENT MANAGEMENT LLC | 7,872,000 | $8,977,000 | 0.65% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,780,000 | $5,514,000 | 0.63% |